Experience
Sun Pharmaceutical Inds. v. Eli Lilly and Co.
Sun Pharmaceutical Inds.
Eli Lilly and Company
Lead trial and appellate counsel in action to prevent generic competition for anti-cancer drug Gemzar®. One patent sustained. Second method patent found invalid based on expansion of law of double patenting. Left standing on petition for rehearing by 5-4 vote.
Sun Pharmaceutical Inds. v. Eli Lilly and Company, 10-1105, Fed. Cir., Judges Bryson, Gajarsa, Prost
Sun Pharmaceutical Inds. v. Eli Lilly and Company, 2:07-cv-15087, E.D. Mich., Judges Steeh, Whalen